Canine Biologics Launches Adaptive Liquid Nutrition System for Critically Ill or Injured Dogs & Cats

3 years ago

NutriDapt liquid feeding system provides fast, easy, patient-specific nutrition for veterinary patients who need it mostDENVER, CO / ACCESSWIRE /…

GoodCap Pharmaceuticals Announces Publication of International Patent Application

3 years ago

Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap"), a biopharmaceutical company developing low-dose psychedelic therapies, is…

Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

3 years ago

CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…

Melzi Surgical to Participate at the Society of Robotic Surgery 2022 Annual Meeting

3 years ago

Company to showcase the Melzi Sharps Finder, a U.S. FDA registered device designed to locate lost needles and objects for…

9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome

3 years ago

Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel SyndromeRALEIGH, NC / ACCESSWIRE…

Enlighta Announces Appointment of John F. Wallace and Dr. Christina Gong as Independent Directors

3 years ago

TORTOLA, BVI / ACCESSWIRE / June 30, 2022 / Enlighta Inc. (TSXV:NLTA) ("Enlighta" or the "Company") is pleased to announce…

Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products

3 years ago

Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A EventSOUTH EASTON, MA / ACCESSWIRE / June 30, 2022…

SphingoTec Appoints Jörg Menten as CEO to Accelerate Commercialization and Global Growth

3 years ago

SphingoTec appoints Jörg Menten as Chief Executive Officer (CEO) as from July 1, 2022 to drive the commercialization and scale…

9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome

3 years ago

Phase 2 VIBRANT study identifies a dose and dosing interval with >25% improvement in the primary endpoint of 24-hour mean…

Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis

3 years ago

Lung Cancer Orchestrator June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess…